Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases

Archives of Dermatology

Volumn 141, Issue 10, 2005, Pages 1235-1242

  Trento, Elisabetta ^a   Castilletti, Concetta ^b   Ferraro, Carmela ^a   Lesnoni La Parola, Ilaria ^a   Mussi, Anna ^a   Muscardin, Luca ^a   Bordignon, Valentina ^a   D'Agosto, Giovanna ^a   Amantea, Ada ^a   Mastroianni, Antonio ^a   Ameglio, Franco ^c   Fluhr, Joachim ^d   Cordiali Fei, Paola ^a  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c General Hospital S Giovanni Calibita   (Italy)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; MONOCLONAL ANTIBODY; T LYMPHOCYTE RECEPTOR; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; BLOOD ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; HEALTH SURVEY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; LARGE PLAQUE PARAPSORIASIS; LYMPHOCYTE CLONE; LYMPHOCYTIC INFILTRATION; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MYCOSIS FUNGOIDES; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PARAPSORIASIS; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; SEROPREVALENCE; SKIN INFLAMMATION; SKIN LYMPHOMATOSIS; VIRUS DETECTION; VIRUS LOAD; VIRUS VIRULENCE;

ADULT; AGED; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; GENE REARRANGEMENT; GENOME, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; LYMPHOPROLIFERATIVE DISORDERS; MIDDLE AGED; MYCOSIS FUNGOIDES; OPEN READING FRAMES; PREVALENCE; PSORIASIS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SARCOMA, KAPOSI; SEROEPIDEMIOLOGIC STUDIES; SKIN DISEASES;

EID: 27144497328     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.141.10.1235     Document Type: Article

References (49)

1. Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-1191.
2. Schulz TF. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol. 1998;79:1573-1591.
3. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion. Trends Microbiol. 2000;8:410-418.
4. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995;332:1181-1185.
5. Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood. 1996;88:645-656.
6. Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406-1412.
7. Cesarman E, Moore PS, Rao PH, Inghirami G, Knowles DM, Chang Y. In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood. 1995;86:2708-2714.
8. Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission [published correction appears in Nat Med. 1996;2:1041]. Nat Med. 1996;2:918-924.
9. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet. 1996;348:858-861.
10. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer. 1998;77:361-365.
11. Rezza G, Andreoni M, Dorrucci M, et al. Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. J Natl Cancer Inst. 1999;91:1468-1474.
12. Dupin N, Fisher C, Kellam P, et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci U S A. 1999;96:4546-4551.
13. Henry M, Uthman A, Geusau A, et al. Infection of circulating CD34+ cells by HHV-8 in patients with Kaposi's sarcoma. J Invest Dermatol. 1999;113:613-616.
14. Monini P, Colombini S, Sturzl M, et al. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood. 1999;93:4044-4058.
15. Lechapt-Zalcman E, Challine D, Delfau-Larue MH, Haioun C, Desvaux D, Gaulard P. Association of primary pleural effusion lymphoma of T-cell origin and human herpesvirus 8 in a human immunodeficiency virus-seronegative man. Arch Pathol Lab Med. 2001;125:1246-1248.
16. Said JW, Shintaku IP, Asou H, et al. Herpesvirus 8 inclusions in primary effusion lymphoma: report of a unique case with T-cell phenotype. Arch Pathol Lab Med. 1999;123:257-260.
17. Rabkin CS, Bedi G, Musaba E, et al. AIDS-related Kaposi's sarcoma is a clonal neoplasm. Clin Cancer Res. 1995;1:257-260.
18. Judde JG, Lacoste V, Brière J, et al. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. J Natl Cancer Inst. 2000;92:729-736.
19. Dupin N, Franck N, Calvez V, et al. Lack of evidence of human herpesvirus 8 DNA sequences in HIV-negative patients with various lymphoproliferative disorders of the skin. Br J Dermatol. 1997;136:827-830.
20. Nagore E, Ledesma E, Collado C, Oliver V, Pérez-Pérez A, Aliaga A. Detection of Epstein-Barr virus and human herpesvirus 7 and 8 genomes in primary cutaneous T- and B-cell lymphomas. Br J Dermatol. 2000;143:320-323.
21. Katano H, Iwasaki T, Baba N, et al. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol. 2000;74:3478-3485.
22. Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus-8, diseases. Clin Microbiol Rev. 2002;15:439-464.
23. Basarab T, Fraser-Andrews EA, Orchard G, Whittaker S, Russel-Jones R. Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases. Br J Dermatol. 1998;139:630-638.
24. Zackheim HS, Jones C, Leboit PE, Kashani-Sabet M, McCalmont TH, Zehnder J. Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality [published correction appears in J Am Acad Dermatol. 2004;50:202]. J Am Acad Dermatol. 2003;49:620-623.
25. Lambert WC, Everett MA. The nosology of parapsoriasis. J Am Acad Dermatol. 1981;5:373-395.
26. Sanchez JL, Ackerman AB. The patch stage of mycosis fungoides: criteria for histologic diagnosis. Am J Dermatopathol. 1979;1:5-26.
27. Everett MA. Early diagnosis of mycosis fungoides: vacuolar interface dermatitis. J Cutan Pathol. 1985;12:271-278.
28. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sezary syndrome (cutaneous T-cell lymphoma): a review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol. 1994;18:645-667.
29. Smoller BR, Bishop K, Glusac E, Kim YH, Hendrickson M. Reassessment of histologic parameters in the diagnosis of mycosis fungoides. Am J Surg Pathol. 1995;19:1423-1430.
30. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 1995;332:1186-1191.
31. Nagasawa T, Nakatsuka S, Miwa H, et al. Analysis of T-cell antigen receptor gamma chain gene rearrangement by polymerase chain reaction in combination with denaturing gradient gel electrophoresis in the differential diagnosis of cutaneous T-lymphoproliferative diseases. J Dermatol. 2000;27:238-243.
32. Wood GS, Tung RM, Haeffner AC, et al. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE). J Invest Dermatol. 1994;103:34-41.
33. Plancoulaine S, Abel L, Gessain A. Epidemiology of human herpes virus 8 (HHV-8) or the herpes virus associated with Kaposi's sarcoma (KSHV) [in French]. Pathol Biol. 2002;50:496-502.
34. Verbeek W, Frankel M, Miles S, Said J, Koeffler HP. Seroprevalence of HHV-8 antibodies in HIV-positive homosexual men without Kaposi's sarcoma and their clinical follow-up. Am J Clin Pathol. 1998;109:778-783.
35. Crum N, Wallace MR, Stephan K, et al. Correlates of human herpesvirus-8 seropositivity among US military members recently infected with human immunodeficiency virus. Sex Transm Dis. 2003;30:713-718.
36. Serraino D, Toma L, Andreoni M, et al. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol. 2001;17:871-876.
37. Cattani P, Capuano M, Cerimele F, et al. Human herpesvirus-8 seroprevalence and evaluation of nonsexual transmission route by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol. 1999;37:1150-1153.
38. Sarmati L, Carlo T, Rossella S, et al. Human herpesvirus-8 infection in pregnancy and labor: lack of evidence of vertical transmission. J Med Virol. 2004;72:462-466.
39. Corchero JL, Mar EC, Spira TJ, Pellett PE, Inoue N. Comparison of serologic assays for detection of antibodies against human herpesvirus 8. Clin Diagn Lab Immunol. 2001;8:913-921.
40. Schatz O, Monini P, Bugarini R, et al. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol. 2001;65:123-132.
41. Beyari MM, Hodgson TA, Cook RD, et al. Multiple human herpesvirus-8 infection. J Infect Dis. 2003;188:678-689.
42. Casper C, Krantz E, Taylor H, et al. Assessment of a combined testing strategy for detection of antibodies to human herpesvirus 8 (HHV-8) in persons with Kaposi's sarcoma, persons with asymptomatic HHV-8 infection, and persons at low risk for HHV-8 infection. J Clin Microbiol. 2002;40:3822-3825.
43. Nevala H, Karenko L, Väkevä L, Ranki A. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Br J Dermatol. 2001;145:928-937.
44. Gniadecki R, Rossen K. Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis. Br J Dermatol. 2003;148:885-891.
45. Simon M, Flaig MJ, Kind P, Sander CA, Kaudewitz P. Large plaque parapsoriasis: clinical and genotypic correlations. J Cutan Pathol. 2000;27:57-60.
46. Ensoli B, Sgadari C, Barillari G, Sirianni MC, Sturzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer. 2001;37:1251-1269.
47. Hudnall SD, Rady PL, Tyring SK, Fish JC. Serologic and molecular evidence of human herpesvirus 8 activation in renal transplant recipients. J Infect Dis. 1998;178:1791-1794.
48. Beylot-Barry M, Sibaud V, Thiebaut R, et al. Evidence that an identical T cell clone in skin and peripheral blood lymphocytes is an independent prognostic factor in primary cutaneous T cell lymphomas. J Invest Dermatol. 2001;117:920-926.
49. Klemke CD, Dippel E, Dembinski A, et al. Clonal T cell receptor gamma-chain gene rearrangement by PCR-based GeneScan analysis in the skin and blood of patients with parapsoriasis and early-stage mycosis fungoides. J Pathol. 2002;197:348-354.